Sihuan Pharmaceutical Holdings Group Ltd ADR SHPHY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $4.36
- Day Range
- $4.40–4.40
- 52-Week Range
- $4.36–4.40
- Bid/Ask
- $0.01 / $534,004.60
- Shares Outstanding
- 227.90M
- Market Cap
- $1.02B
- Volume/Avg
- 250 / 250
Key Statistics
- Price/Earnings (Normalized)
- 34.13
- Price/Sales
- 2.64
- Dividend Yield (Trailing)
- 1.27%
- Dividend Yield (Forward)
- 1.27%
- Dividend Payment Schedule
- Jul, Oct
- Total Yield
- 3.76%
Company Profile
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment, including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the innovative medicine and other medicine segment; and the generic medicine segment, which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 2,712
- Website
- https://www.sihuanpharm.com
Valuation
|
Metric
|
SHPHY
|
|---|---|
Price/Earnings (Normalized) | 34.13 |
Price/Book Value | 1.11 |
Price/Sales | 2.64 |
Price/Cash Flow | 16.47 |
Price/Earnings
SHPHY
Financial Strength
|
Metric
|
SHPHY
|
|---|---|
Quick Ratio | 1.55 |
Current Ratio | 1.80 |
Interest Coverage | 4.34 |
Quick Ratio
SHPHY
Profitability
|
Metric
|
SHPHY
|
|---|---|
Return on Assets (Normalized) | 2.29% |
Return on Equity (Normalized) | 4.73% |
Return on Invested Capital (Normalized) | 4.66% |
Return on Assets
SHPHY
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|G<!K!Ybt | LOCK|FC!LW | $70B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|CM%!^NJ | LOCK|l?KgG | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|d^q>PBQ | LOCK|xM | $45B | |||
| Zoetis Inc Class A
ZTS
| LOCK|QTml@^x | LOCK|Q<@ | $33B | |||
| Viatris Inc
VTRS
| LOCK|ZMV@N^ | LOCK|%w | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|St | LOCK|s$ | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|wCQrp> | LOCK|?bm | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|Mq%r<GP | LOCK|!% | $6B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|Q#mLSX | LOCK|bD?> | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|J#VR!Y | LOCK|T&% | $2B |
United States